Descriptions:
| Term | description type | Language/acceptability | Language/acceptability | Case significance |
|---|---|---|---|---|
| [therapeutic role] therapeutic role (role) | FSN | us:P | gb:P | ci |
| [therapeutic role] therapeutic role | SYN | us:P | gb:P | ci |
Concept model:
| Attribute cardinality | Attribute | Value | role group number | role group cardinality |
|---|---|---|---|---|
| 1..1 | 0 | N/A | ||
| 1..* | 0 | 1..* |
Definition status:
Applies to:
< 763158003 |Medicinal product (product)|
Rules for description generation:
- Apply General rules for generating descriptions for templates
- 'and [substance]' needs to be added for FSN for multiple |has active ingredient| and they are self-grouped, e.g. Product containing calcium carbonate and sodium bicarbonate (medicinal product)
- '[substance]- and' needs at the beginning of the description to be added for PT for multiple |has active ingredient| and they are self grouped, e.g. Calcium carbonate- and sodium bicarbonate-containing product
- For multiple ingredients, the ingredients in each description need to be in alphabetical order e.g. Codeine and paracetamol for FSN but Acetaminophen and codeine (for US PT).
JIRA ticket for implementation:
DRUGS-273 - Getting issue details... STATUS
INFRA-3023 - Getting issue details... STATUS
DRUGS-641 - Getting issue details... STATUS